Search results for "malaria"

Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea

The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape

Collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain

The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis

Gentle and rapid detachment of in vitro cultured cells

6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds

Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

Platform enables direct measure of more than 10,000 proteins in diverse FFPE tissue and tumor samples, integrated multi-omic molecular mapping of tumors

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Researchers are uncovering previously unknown sources of PFAS using robotic sample preparation and high-resolution mass spectrometry

Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation